Halo Labs Revenue Triples After Expansion into California & Nevada


Ryan Allway

May 17th, 2019

App, Exclusive, News, Top Story


Halo Labs Inc. (NEO: HALO) (OTCQX: AGEEF) revenue tripled to more than $8.7 million after launching cannabis oil and concentrate operations in California and Nevada.

The company’s California operations generated $5,324,396 in revenue; it’s Nevada-based business generated $514,365 in revenue; and its existing Oregon operations reported a 32.8% increase in revenue to $2,168,975 for the quarter.

While the company has roots in Oregon, its California business has quickly become the biggest growth driver. California-based operations generated $1,865,542 in EBITDA, which offset operating losses of $618,400 in Oregon and $299,371 in Nevada, to achieve aggregate EBITDA of $929,260 for the quarter.

The California businesses’ gross margins were a robust 39.7%, which was significantly higher than the 8% in Oregon and 3.9% in Nevada. While the Oregon business reported a 4% increase in average selling prices, the Nevada business’ gross margins were temporarily depressed due to high inventory costs as a result of FIFO inventory accounting. These margins are projected to normalize in the second quarter.

The company used approximately $2 million in cash and raised a $1.7 million bridge financing to end the quarter with about $360,000 in cash and cash equivalents.

Click here to receive an investor presentation and additional Company updates

Positive Outlook

Halo Labs anticipates that it’s Coastal Harvest will continue to be a strong growth driver for revenue and profitability. With the launch of DabTab™ Dablets and other initiatives, the subsidiary is already operating at an annualized production rate of about $25 million. New distributor agreements could further improve these figures and cement its leadership position.

In addition to these efforts, the company continues to launch new higher margin products across all three markets. The company introduced its first edible line in November 2018, DabTabs™ Dablets in late March, and DabTab GO™ in early-May. These products could further enhance average selling prices and help improve overall EBITDA.

The company also secured a hemp processing facility in mid-April that will power its entry into the market for cannabidiol (CBD) products. The facility is expected to process about 10,000 kilograms of hemp per month when fully operational, which could yield 700 to 900 kilograms of high-grade distillate or isolate CBD each month.

Outside of the United States, the company has begun operations in Lesotho, Africa through a strategic partnership. The country was the first in Africa to regulate medical marijuana and its regulations were crafted with exports in mind. The company’s focus on cannabis oils and concentrates sets it apart from many others in the country.

HALO Labs – The Journey of a pioneer in Cannabis Extraction and Oils. Please click this link to see a video on HALO Labs.

 

Looking Ahead

Halo Labs Inc. (NEO: HALO) (OTCQX: AGEEF) represents a unique opportunity to invest in a multi-state operator focused on cannabis oils and concentrates. With its proven success in Oregon, the company is quickly expanding into new states to increase revenue and launching new higher margin products to increase profitability. The company’s upcoming move into the CBD market could also prove to be a catalyst for further growth.

Click here to receive an investor presentation and additional Company updates

For more information, visit the company’s website at www.halocanna.com.

Disclaimer

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-disclaimer/

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading